Following advice and recommendations by the Joint Committee on Vaccination and Immunisation (JCVI), and in line with standing commitments on patient rights under the NHS constitution on implementing such recommendations, a series of changes to England's national immunisation programme took place from July 2013 including the introduction of Rotavirus vaccine (Rotarix® by GlaxoSmithKline Biologicals s.a.) into the routine childhood UK schedule for babies from 2 months of age .
|Journal||Journal of Vaccines and Vaccination|
|Publication status||Published - 2014|
ASJC Scopus subject areas
- Immunology and Allergy
- Drug Discovery